Found: 1
Select item for more details and to access through your institution.
The effect of renal function on the pharmacokinetics and pharmacodynamics of enavogliflozin, a potent and selective sodium‐glucose cotransporter‐2 inhibitor, in type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 7, p. 2588, doi. 10.1111/dom.15573
- By:
- Publication type:
- Article